Learn about the causes, symptoms and treatment options for Parkinson's disease including the experimental stem cell therapy and traditional options like medications, surgery and rehabilitation therapy.
Stem cell therapy for Parkinson's disease is a treatment approach that involves using stem cells, which are undifferentiated cells that can develop into various types of specialized cells, to replace or repair damaged or lost cells in the brain associated with Parkinson's disease.
Several preclinical studies using animal models have suggested the potential benefits of mesenchymal stem cells (MSCs) for Parkinson's disease. The studies that have been conducted commonly show positive results; however, they have generally been small and have used different methods of transplantation and sources of mesenchymal stem cells (MSCs).
Stem cell therapy may benefit Parkinson's Disease by replacing and repairing damaged dopamineproducing nerve cells within the brain. One study published in the journal
"Stem Cells Translational Medicine" in 2016 reported the results of a phase I clinical trial in which MSCs derived from bone marrow were transplanted into the brains of 12 patients with Parkinson's disease.
Stem cell therapy for Parkinson's disease is still considered exploratory and more research is needed to determine its long-term effectiveness. However, preclinical and clinical studies using mesenchymal stem cells (MSCs) have suggested exciting benefits for treating Parkinson's disease, including:
• Replacement or repair of lost or damaged dopamine-producing cells in the brain.
• Improve motor function and reduce symptoms such as tremors, stiffness, and difficulty with movement.
• Reduction in inflammation and oxidative stress in the brain, which is thought to contribute to the development of Parkinson's disease.
• Improvement in the function of the immune system leads to condition stabilization or potentially extended
Parkinson's Disease is a chronic illness affecting millions worldwide. Diagnosing Parkinson's Disease can be challenging, as symptoms may be similar to other movementrelated disorders, such as multiple system atrophy or Lewy body dementia.
